Navigation Links
Auxogyn Announces Strategic Partnership with Valencia Infertility Institute (IVI)
Date:7/25/2013

MENLO PARK, Calif., July 25, 2013 /PRNewswire/ -- Auxogyn, Inc., a company focused on revolutionizing the field of reproductive medicine by providing novel scientific and clinically validated solutions to IVF clinicians and their patients, today announced it has entered into a strategic partnership with the Valencia Infertility Institute (IVI), a global leader in reproductive medicine with 23 clinics throughout the world.

Under the terms of this multi-year agreement, Auxogyn will install its Early Embryo Viability Assessment (Eeva™) systems at IVI clinics to support two Auxogyn-led research initiatives: the Eeva Pregnancy Investigational Clinical (EPIC) Study and an aneuploidy research program. IVI will use the Eeva systems to treat at least 200 patients participating in the EPIC Study in Europe, which will evaluate the impact on clinical pregnancy rates of improved embryo selection with the Eeva Test. This partnership will also support Auxogyn's current aneuploidy (an abnormal number of chromosomes) research programs, which – by leveraging the Eeva system – could lead to the development of non-invasive, automated methods for aneuploidy screening.

"Auxogyn is very pleased to collaborate with IVI, which has one of the world's largest networks of IVF clinics and a proven track record of promoting clinical and scientific progress through cutting-edge research," stated Lissa Goldenstein, President and CEO of Auxogyn. "Through this partnership, we're accelerating our growth in Europe and advancing our mission of improving outcomes for patients undergoing IVF."

Installation of the Eeva systems at IVI clinics in Spain is scheduled to occur in August 2013. These will be the first clinics in Spain to offer this innovative technology to eligible patients who enroll in th
'/>"/>

SOURCE Auxogyn, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014 Sanofi Pasteur, the ... SNY ), announced today that the first lots of Fluzone ... season have been released by the U.S. Food and Drug ... 21, 2014, representing the first of at least 65 million ... will be delivered to U.S. health care providers and pharmacies ...
(Date:7/22/2014)... Israel , July 22, 2014 Galmed ... clinical-stage biopharmaceutical company focused on the development and commercialization ... liver diseases and cholesterol gallstones, announced today that the ... Galmed,s Investigational New Drug, or IND, application.  Such clearance ... product candidate, aramchol, in the United States ...
(Date:7/22/2014)... -- Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. (OTCQB: ... the Icahn School of Medicine at Mount ... to utilize its proprietary information and data package for ... Type C Disease (NPC), a rare disease, mostly of ... also covers other diseases and disorders relying on activation ...
Breaking Medicine Technology:Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 2Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 3Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
... N.J., June 24, 2011 Laureate Biopharmaceutical Services, ... Drug Administration ("FDA") approved its application for an ... gateway will allow Laureate to offer clients a ... Drug), NDA (New Drug Application) and BLA (Biologic ...
... June 24, 2011 Elekta,s Leksell Gamma Knife® Perfexion™ earned ... released 2011 Top 20 Best in KLAS Awards: Medical ... in the radiation therapy category. In the ... of customers indicated they would buy again. On a 1 ...
Cached Medicine Technology:Laureate's Electronic Submission Gateway Approved 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 3
(Date:7/22/2014)... (Boston)-- Researchers from Boston University School of Medicine ... that participants who received care through BMC,s Violence ... physical, mental, emotional and social needs of violently ... injuries and experienced life changing behaviors through connections ... feel trust and hope. These findings are reported ...
(Date:7/22/2014)... The European Bio stimulants Market report defines ... analysis and forecast of revenue. The bio stimulants market ... million in 2013 to $940.6 million by 2018, at ... Browse through the TOC of the Europe Bio stimulants ... analysis provided. , http://www.micromarketmonitor.com/market/europe-bio-stimulants-1315565884.html , Agriculture contributes ...
(Date:7/22/2014)... California (PRWEB) July 22, 2014 In ... women in recovery, the Marinello School of Beauty joined ... Addiction Treatment Center for a free “Make-over Day.” ... to be of service to the community, and The ... and renewed. They also gained some first-hand experience about ...
(Date:7/22/2014)... 2014 Expert Publishing ... , announces the launch of PoisonEXPERT™ , ... safety professionals employed by organizations that use or ... manage the impact of chemicals on their employees ... relevant chemical-specific information and medical protocols that allows ...
(Date:7/22/2014)... Transparency Market Research has announced the ... Diagnostics Market – Global Industry Analysis, Size, Share, Growth, ... comprehensive database. This industry is considered as the most ... valued at USD 8.7 billion by 2019 and expected ... to 2019. Molecular diagnostics is the class of diagnostic ...
Breaking Medicine News(10 mins):Health News:Clients of BMC's violence interventional advocacy program find experience supportive 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:The Discovery House 'Make-over Day' Adds Pampering To Recovery 2Health News:The Discovery House 'Make-over Day' Adds Pampering To Recovery 3Health News:PoisonEXPERT™ from ExPub Now Available 2Health News:PoisonEXPERT™ from ExPub Now Available 3Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 2Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 3Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 4
... a Diet High in Fruits and Vegetables ,Healthy Foods ... patients with kidney disease, the Western diet produces an acidic ... worsens with age as kidney function declines. Nimirit Goraya, MD ... and her colleagues conducted a study to see if consuming ...
... By Ellin Holohan HealthDay Reporter , FRIDAY, ... against alcohol use, can relax and have a drink a ... weight, two new Dutch studies show. The researchers found ... be unfounded, while concerns about weight are not. Both ...
... 19 (HealthDay News) -- A new, small study suggests that the ... dose of tamoxifen, a drug commonly used to prevent and treat ... cough medicine at about the same rate as tamoxifen, allowing doctors ... drug. "This study is starting to identify a personalized ...
... NEW YORK (Nov. 20, 2010) Columbia University Medical ... a Harvard researcher who has made important advances in ... and heart disease. A promising young investigator at Columbia ... the basis for disordered lipid metabolism in diabetes. ...
... By Madonna Behen HealthDay Reporter , FRIDAY, Nov. ... on U.S. college campuses, college officials are trying various ways ... targeted off-campus boozing shows some promise, researchers say. ... cut the level of heavy drinking at private parties and ...
... 19, 2010 University of Houston (UH) physicists are ... a crucial protein that, when malfunctioning, may cause Alzheimer,s ... physics at UH, and Antonios Samiotakis, a physics Ph.D. ... function, and folding of phosphoglycerate kinase (PGK) are strongly ...
Cached Medicine News:Health News:Kidneys: Produce-rich diet improves long-term health, melatonin improves short-term health 2Health News:Kidneys: Produce-rich diet improves long-term health, melatonin improves short-term health 3Health News:Moderate Drinking Could Lower Death Risk for Kidney Transplant Patients 2Health News:Moderate Drinking Could Lower Death Risk for Kidney Transplant Patients 3Health News:Moderate Drinking Could Lower Death Risk for Kidney Transplant Patients 4Health News:Cough Syrup Might Help With Dosing of Breast Cancer Drug 2Health News:Harvard expert on inflammation's role in obesity receives Columbia's 2010 Naomi Berrie Award 2Health News:Harvard expert on inflammation's role in obesity receives Columbia's 2010 Naomi Berrie Award 3Health News:Harvard expert on inflammation's role in obesity receives Columbia's 2010 Naomi Berrie Award 4Health News:Outreach, Enforcement Can Curb College Kids' Drinking: Study 2Health News:Outreach, Enforcement Can Curb College Kids' Drinking: Study 3Health News:UH physicists study behavior of enzyme linked to Alzheimer's, cancer 2Health News:UH physicists study behavior of enzyme linked to Alzheimer's, cancer 3